Pathwork Diagnostics Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $200K

Pathwork Diagnostics General Information

Description

Developer of molecular diagnostics for oncology. The company offers Pathwork tissue of origin test, a molecular diagnostics gene expression-based test that uses a tumor's genomic information to aid in the identification of tumors, including poorly differentiated, undifferentiated, and metastatic tumors. Its tissue of origin test includes lab service tests for formalin-fixed, paraffin-embedded, or frozen specimens.

Contact Information

Formerly Known As
Predicant Biosciences, Biospect
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 595 Penobscot Drive
  • Redwood City, CA 94063
  • United States
+1 (650)
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 595 Penobscot Drive
  • Redwood City, CA 94063
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pathwork Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 26-Aug-2013 $200K Completed Generating Revenue
5. Later Stage VC (Series C) 06-Oct-2010 Completed Generating Revenue
4. Early Stage VC (Series B) 04-Sep-2008 Completed Generating Revenue
3. Debt - General 11-Oct-2005 Completed Startup
2. Early Stage VC (Series A1) 24-Jun-2005 $27.9M $31.9M Completed Startup
1. Early Stage VC (Series A) 18-Jul-2002 $4M $4M Completed Startup
To view Pathwork Diagnostics’s complete valuation and funding history, request access »

Pathwork Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series C1
Series B
Series 2 9,500,000 $0.000100 $0.09 $1.5 $1.5 1x $1.5 8.3%
Series 1 2,000,000 $0.000100 $1.5 $1.5 1x $1.5 1.75%
To view Pathwork Diagnostics’s complete cap table history, request access »

Pathwork Diagnostics Patents

Pathwork Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20050069863-A1 Computer program product which use preferential transcriptional products as tool in detection and diagnosis of cell proliferative disorders; statistical modeling and disease detection Inactive 29-Sep-2003
EP-1678575-A2 Knowledge-based storage of diagnostic models Inactive 29-Sep-2003
EP-1678575-A4 Knowledge-based storage of diagnostic models Inactive 29-Sep-2003
JP-2012065674-A System and method for detecting biological feature Inactive 29-Sep-2003
EP-1690086-A2 Systems and methods for analyzing gene expression data for clinical diagnostics Inactive 29-Sep-2003 G16B40/20
To view Pathwork Diagnostics’s complete patent history, request access »

Pathwork Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pathwork Diagnostics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Advent Venture Partners Venture Capital Minority
Alta Partners Venture Capital Minority
Novus Ventures Venture Capital Minority
Prospect Venture Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Pathwork Diagnostics FAQs

  • When was Pathwork Diagnostics founded?

    Pathwork Diagnostics was founded in 2002.

  • Where is Pathwork Diagnostics headquartered?

    Pathwork Diagnostics is headquartered in Redwood City, CA.

  • What is the size of Pathwork Diagnostics?

    Pathwork Diagnostics has 24 total employees.

  • What industry is Pathwork Diagnostics in?

    Pathwork Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Pathwork Diagnostics a private or public company?

    Pathwork Diagnostics is a Private company.

  • What is the current valuation of Pathwork Diagnostics?

    The current valuation of Pathwork Diagnostics is .

  • What is Pathwork Diagnostics’s current revenue?

    The current revenue for Pathwork Diagnostics is .

  • How much funding has Pathwork Diagnostics raised over time?

    Pathwork Diagnostics has raised $89.4M.

  • Who are Pathwork Diagnostics’s investors?

    Abingworth, Advent Venture Partners, Alta Partners, Novus Ventures, and Prospect Venture Partners are 5 of 9 investors who have invested in Pathwork Diagnostics.

  • When was Pathwork Diagnostics acquired?

    Pathwork Diagnostics was acquired on 26-Aug-2013.

  • Who acquired Pathwork Diagnostics?

    Pathwork Diagnostics was acquired by Response Genetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process